12 изменений, которые происходят с вашим организмом, когда вы начинаете принимать

Wegovy, a popular weight-loss drug, is causing a shortage in Britain just months after its release. This drug, also known as Ozempic in a lower-dose version, has shown impressive results in trials, with some participants losing up to a fifth of their body weight in a year. The key to Wegovy's success lies in its ability to suppress hunger pangs. By mimicking the effects of a hormone called glucagon-like peptide-1 GLP-1, the drug signals to the brain that the stomach is full even after consuming minimal amounts of food.

As a result, cravings for favorite dishes disappear within weeks of starting the treatment. In addition to curbing appetite, Wegovy also slows down digestion, prolonging the feeling of fullness. While this can be beneficial for weight loss, there are potential downsides. Studies have shown that around 1 in 100 people on GLP-1 drugs develop gastroparesis, a condition where weak stomach muscle contractions lead to difficulties in digesting food and can cause nausea and vomiting.

Constipation is also a common side effect in these cases. Another advantage of Wegovy is its potential to increase calorie burning at rest, although the exact mechanism behind this effect is not fully understood. Furthermore, the drug has shown positive effects on heart health. It not only aids in weight loss, which is beneficial for the heart, but also reduces inflammation in blood vessels, lowering the risk of heart attacks and strokes.

Surprisingly, these benefits were observed even before patients reached their maximum weight loss, suggesting that the drug has a direct impact on heart health. Interestingly, some individuals have reported a reduced desire to consume alcohol while taking Wegovy. Studies have shown that the drug dampens the brain's reward response to alcohol, decreasing the urge to drink. Additionally, Wegovy, like its counterpart Ozempic, can significantly reduce blood sugar levels by promoting the release of insulin from the pancreas.

This helps to stabilize blood sugar levels and reduce the risk of type 2 diabetes. While Wegovy offers numerous benefits, there are also some potential drawbacks. Some users have reported experiencing foul-smelling burps, possibly due to changes in gut bacteria caused by the drug. Additionally, rapid weight loss associated with Wegovy can lead to accelerated facial aging, with more wrinkles and saggy skin.

This occurs as facial fat diminishes, reducing collagen levels and affecting the skin's strength and flexibility. On a positive note, Wegovy has been found to combat fatty liver disease, a significant health problem in the UK. By injecting the drug once a week, individuals may unknowingly be improving their liver health. Furthermore, as excess weight is shed, patients often experience increased energy levels.

This is attributed to improved oxygen levels in the blood, as obesity can hinder proper breathing and reduce oxygen intake. Weight loss with Wegovy can also alleviate heavy snoring, a common issue among obese individuals. The drug helps reduce fat around the neck, which can obstruct airways during sleep and lead to sleep apnea. Lastly, there have been concerns about the potential psychological effects of Wegovy and similar drugs.

Reports of patients experiencing suicidal thoughts or self-injury have raised alarm, but studies have not found conclusive evidence linking these drugs to an increase in such thoughts. It is important to note that severe weight loss can trigger depression in some individuals due to the challenges of adjusting to new dietary restrictions. In conclusion, Wegovy has emerged as a highly sought-after weight-loss drug due to its ability to suppress appetite, slow digestion, increase calorie burning, improve heart health, and reduce blood sugar levels.

However, potential side effects such as gastroparesis, foul-smelling burps, accelerated facial aging, and psychological concerns should be taken into consideration. As with any medication, it is crucial to consult with a healthcare professional before starting treatment.

НОВОСТИ ПО ТЕМЕ